Exagen
XGN
47 hedge funds and large institutions have $46.4M invested in Exagen in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 25 reducing their positions, and 13 closing their positions.
9.92% more ownership
Funds ownership: 56.01% → 65.93% (+9.9%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 53 → 47 (-6)
36% less capital invested
Capital invested by funds: $73M → $46.4M (-$26.6M)
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
60% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HT
HighTower Trust
Houston,
Texas
|
+$15.6M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$811K |
| 3 |
Millennium Management
New York
|
+$464K |
| 4 |
E
Ergoteles
New York
|
+$292K |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$210K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$2.9M |
| 2 |
CCPM
Cooper Creek Partners Management
New York
|
-$1.23M |
| 3 |
N
Natixis
Paris,
France
|
-$1M |
| 4 |
CPA
Cowen Prime Advisors
New York
|
-$576K |
| 5 |
State Street
Boston,
Massachusetts
|
-$572K |
XGN Hedge Fund Activity: Q2 2022 in Review
47 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q2 2022, worth a combined $46.4M — down 36% from $73M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of XGN and 8 opened new positions — a net loss of 5 holders — while 25 trimmed existing stakes and 10 added.
The largest buyer was HighTower Trust, opening a new position worth an estimated $15.6M. The largest seller was BlackRock, cutting an estimated $2.9M.
- 47 institutional investors held Exagen (XGN) as of Q2 2022, down from 53 in Q1 2022.
- Funds reported $46.4M of Exagen stock for Q2 2022, down 36% quarter-over-quarter.
- 8 funds opened new Exagen positions in Q2 2022 and 13 closed out, a net change of -5 holders.
- The largest Exagen buyer in Q2 2022 was HighTower Trust, an estimated $15.6M added.
- The largest Exagen seller in Q2 2022 was BlackRock, an estimated $2.9M sold.
Based on aggregated 13F filings for Q2 2022.